News and Events

FyoniBio collaborates with BioLamina and Alder Therapeutics

FyoniBio, Alder Therapeutics, and BioLamina enter Consortium Grant Agreement to Propel Recombinant Human Laminin Development for Clinical Applications.

FyoniBio gets CIR accreditation

We are pleased to announce that FyoniBio has received CIR (Crédit d’Impôt Recherche or CIR) accreditation for three years until 2025, which will benefit our French clientele.

Launch of FyoniBio’s CHOFlow® Technology

CHOFlow®: Our high yield expression technology for afucosylated ADCC enhanced antibodies and beyond.

Successful Cell Line Development for Strike Pharma

Strike Pharma and FyoniBio Conclude Successfully Cell Line Development of Strike’s Bi-specific Antibody and Clinical Lead Candidate.

Service Agreement with adivo

FyoniBio and adivo GmbH sign a Service Agreement covering the generation of a production cell line for their canine therapeutic mAb candidate

Cooperation with Strike Pharma

We have signed a Master Service Agreement with Strike Pharma covering the cell line development for a novel bi-specific therapeutic mAb.

Partnership with ProteoNic

We have signed a license agreement for using ProteoNic’s 2G Unic™ technology in our cell line development platform.

Launch of FyoniBio GmbH

The FyoniBio service branch of Glycotope GmbH will continue its business as FyoniBio GmbH.

Cooperation with BioGenes

BioGenes and FyoniBio begin a cooperation for Pharmacokinetic & Immunogenicity Analyses

Collaboration with CSL Behring

We are happy to have initiated a collaboration with CSL Behring research division.

COG Nordics

Meet FyoniBio at the leading event for clinical operations and research professionals in the Nordic region in Malmö, Sweden! This premier gathering brings together industry experts, regulatory authorities, academic leaders under one roof to address the cutting-edge development in clinical trials, drug development and patient centric research.

1–2 April 2025

CPHI Japan 2025

FyoniBio is excited to be part of CPHI, a global hub for building connections and driving innovation in the pharmaceutical industry. This event in Tokyo brings together experts, businesses, and partners to explore new opportunities and shape the future of pharma.

9–11 April 2025

HDDC 2025

FyoniBio is delighted to attend the Helmholtz Drug Discovery Conference 2025 (HDDC2025)—a premier and international event that takes place biannually, bringing together scientists from academia, biotech, and the pharmaceutical industry.

28-30 April 2025